Shiyu Wang
Company: Sanegene Bio
Job title: Chief Scientific Officer
Seminars:
Upstream vs. Downstream Targeting in GA & AMD 1:00 pm
Discussing the advantages and disadvantages of different complement targets through an ophthalmology lens Delivering complement inhibitors to the eye: topical, intravitreal, or systemic? Future considerations for combination therapies to target multiple complement components in the eyeRead more
day: Conference Day Two
Ligand & Enhancer Assisted Delivery for RNAi Complement Inhibitors 2:00 pm
Targeting C3 with siRNA Delivering a GalNAc conjugate to the liver using the LEAD GalNac platform Discussing optimal dosage for long-term efficacyRead more
day: Conference Day One